Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled Trial

This publication has 34 references indexed in Scilit:

• Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
  The Journal of Thoracic and Cardiovascular Surgery, 2007
• Reverse right ventricular remodeling after pulmonary endarterectomy
  The Journal of Thoracic and Cardiovascular Surgery, 2006
• Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
  The Annals of Thoracic Surgery, 2006
• Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions
  Annals of the Rheumatic Diseases, 2006
• Assessment of Operability in Chronic Thromboembolic Pulmonary Hypertension
  Proceedings of the American Thoracic Society, 2006
• Techniques and Outcomes of Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension
  Proceedings of the American Thoracic Society, 2006
• Long-Term Bosentan in Chronic Thromboembolic Pulmonary Hypertension
  Respiration, 2006
• Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study
  The Lancet, 2001
• Acute and chronic effects of surgical thromboendarterectomy on exercise capacity and ventilatory efficiency in patients with chronic thromboembolic pulmonary hypertension
  Heart, 2001
• PULMONARY VASCULAR REMODELING DISTAL TO PULMONARY ARTERY LIGATION IS ACCOMPANIED BY UPREGULATION OF ENDOTHELIN RECEPTORS AND NITRIC OXIDE SYNTHASE
  Experimental Lung Research, 2000